IHH Healthcare Bhd.
- 5.59 MYR
- -0.09
- -1.58%
Malaysia
Aug 23, 2019Ticker
KLS(5225)Prev. close
5.68Market cap (MYR)
49,836.30MMarket cap (USD)
11,889.80MShares
8,773.99M
In the news
- Malaysia sovereign wealth fund marks $1.5bn loss over impairments Mar 6, 2019
- Raffles Medical's future hinges on China hospitals Nov 29, 2018
- Malaysia state fund to sell $2bn stake in IHH Healthcare to Mitsui Nov 29, 2018
- Modicare puts hospitals at risk, Indian companies warn Nov 15, 2018
- IHH Healthcare in talks to expand in North India May 28, 2018 See more articles on IHH Healthcare Bhd.
Company Background
IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.
Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.
IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.
IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.
Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.
Business Summary
Financial Highlights
| Dec 2018 | MYR | USD |
| Revenue | 11,520.93M | 2,854.98M |
| Gross Profit | 2,902.27M | 719.20M |
| Operating income | 1,240.72M | 307.46M |
| Income before tax | 739.05M | 183.14M |
| Net income | 541.84M | 134.27M |
| EBITDA | 2,162.14M | 535.79M |
| Diluted EPS | 0.06 | 0.01 |
| Dividends Per Share | 0.03 | 0.00 |
| Total Assets | 45,114.51M | 10,917.00M |
| Total liabilities | 18,765.36M | 4,540.92M |
| Total equity | 21,994.00M | 5,322.20M |
| Operating cash flow | 1,562.71M | 387.25M |
| Currency in MYR | Currency in USD |
Historical Data
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | |
| Revenue | 7,344.01M | 8,455.46M | 10,021.88M | 11,142.63M | 11,520.93M |
| Gross Profit | 2,020.36M | 2,327.18M | 2,657.91M | 2,620.19M | 2,902.27M |
| Operating income | 1,074.16M | 1,210.55M | 1,227.74M | 1,068.88M | 1,240.72M |
| Income before tax | 1,211.32M | 1,203.25M | 860.94M | 1,162.33M | 739.05M |
| Net income | 754.29M | 933.90M | 612.35M | 931.31M | 541.84M |
| EBITDA | 1,682.34M | 1,900.05M | 2,026.87M | 2,046.96M | 2,162.14M |
| Diluted EPS | 0.09 | 0.11 | 0.07 | 0.11 | 0.06 |
| Dividends Per Share | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Total Assets | 28,680.13M | 35,517.48M | 37,200.39M | 38,925.48M | 45,114.51M |
| Total liabilities | 7,366.73M | 11,280.78M | 13,307.23M | 15,183.41M | 18,765.36M |
| Total equity | 19,451.74M | 22,155.73M | 21,985.74M | 21,890.16M | 21,994.00M |
| Operating cash flow | 1,557.92M | 1,863.97M | 1,730.45M | 2,006.03M | 1,562.71M |
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | |
| Revenue | 2,244.48M | 2,162.70M | 2,419.15M | 2,591.60M | 2,854.98M |
| Gross Profit | 617.46M | 595.23M | 641.58M | 609.41M | 719.20M |
| Operating income | 328.28M | 309.63M | 296.36M | 248.60M | 307.46M |
| Income before tax | 370.20M | 307.76M | 207.82M | 270.34M | 183.14M |
| Net income | 230.52M | 238.86M | 147.81M | 216.60M | 134.27M |
| EBITDA | 514.16M | 485.98M | 489.26M | 476.09M | 535.79M |
| Diluted EPS | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
| Dividends Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 8,202.52M | 8,272.38M | 8,292.55M | 9,618.35M | 10,917.00M |
| Total liabilities | 2,106.88M | 2,627.40M | 2,966.39M | 3,751.77M | 4,540.92M |
| Total equity | 5,563.20M | 5,160.29M | 4,900.96M | 5,408.98M | 5,322.20M |
| Operating cash flow | 476.13M | 476.75M | 417.70M | 466.57M | 387.25M |
Valuation Measures
| Dec 2018 | |
| PER | 82.41 |
| ROA | 1.28% |
| ROE | 2.46% |
| Operating margin | 10.76% |
| Profit margin | 4.70% |
Key executives
- CEO-Designate & Executive Director: Kelvin Loh
- CEO, MD & Non-Independent Executive Director: See Leng Tan
- Group Chief Operating Officer: Suet Wun Lim
- Group Chief Financial Officer: Soon Teck Low
- Group Head-Internal Audit: Audrey Huang
Shareholders
- Mitsui & Co., Ltd. (32.9%)
- Khazanah Nasional Bhd. (Investment Company) (26.0%)
- Employees Provident Fund (7.1%)
- Permodalan Nasional Bhd. (4.8%)
- AYDINLAR MEHMET ALI (4.7%)
- Public Mutual Bhd. (2.1%)
- Kuwait Investment Authority (Investment Management) (1.6%)
- Kumpulan Wang Persaraan (1.5%)
- The Vanguard Group, Inc. (1.1%)
- GIC Pte Ltd. (Investment Management) (1.0%)
Contact Details
- Website:http://www.ihhhealthcare.com
- Address: Level 11 Block A, Pantai Hospital, Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
- Phone: +60.3.2298.9898
Related Companies
- Northern TK Venture Pte Ltd.
- IHH Healthcare Bhd. (Singapore)
- Centre For Digestive & Kidney Diseases India Pvt Ltd.
- Acibadem Saglik Yatirimlari Holding AS
- Indah Capital Ltd.
- Shanghai Mai Kang Hospital Investment Management Co. Ltd.
- Bodrum Tedavi Hizmetleri A.S
- Integrated Healthcare Turkey Yatirimlari Ltd.
- Gleneagles Development Pte Ltd.
- Integrated Healthcare Holdings Ltd.
- Acibadem Saglik Hizmetleri ve Ticaret AS
- Parkway Holdings Ltd.
Competitors
Copyright © 2019 FactSet Research Systems Inc. All rights reserved.
Last Updated on 23 Aug, 2019